Friday, October 23, 2020
Home Uncategorized Pfizer joins hands with IIT to back healthcare innovations in India

Pfizer joins hands with IIT to back healthcare innovations in India

New Delhi: Aiming to back start-ups and individuals for developing healthcare innovations in India, drug giant Pfizer has collaborated with Indian Institute of Technology (IIT) Delhi to launch “Pfizer IIT Delhi innovation and IP Program”.

Under the program, each innovator will get a grant of Rs 50 lakh who will own the patents and would be free to market them as well.

Besides, providing the financial assistance, the program will allow a two-year stay at IIT Delhi and access to all facilities of the institute’s laboratories.

The candidates will also get guidance from Pfizer’s global experts, access to venture capitalists and industrial exposures.

Department of Industrial Policy and Promotion (DIPP) Secretary Amitabh Kant, speaking on the project, said, “the government is taking decisive steps to further enhance the innovation ecosystem in India and we welcome the participation of all stakeholders in this effort”.

“Nurturing entrepreneurship and innovation is a priority for India. In a knowledge economy, the country’s success will be determined by the place it holds on the global innovation platform”, he added.

The high-profile project has been developed jointly by Pfizer and the Foundation for Innovation and Technology Transfer (FITT) at the Indian Institute of Technology.

“Our Innovation and IP Program with IIT Delhi will celebrate, promote, and reward innovations and advancements in healthcare that are born and brought up in India for the benefit of our people,” Pfizer India Executive Director S Sridhar said.

In the 2015-16 fiscal, the program will invite two rounds of proposals. Submission of the first round of proposal begins on November 27 this year.

(With inputs from agencies)



Most Popular

Down Syndrome May Increase COVID Death Risk

Researchers have found that down syndrome is associated with a 10-fold increased risk for COVID-19-related death. Down syndrome (sometimes called Down's syndrome) is a condition...

Miss India 2020 Pageant Held Virtually Due to Pandemic

In the wake of the COVID-19 pandemic, Miss India 2020 pageant will be held virtually the Miss India Organisation has announced. A nationwide audition to...

6 Designers Came Together to Help Craft Clusters Impacted by Pandemic

Six fashion designers came together to support marginalized craft clusters and those heavily impacted by the pandemic by generating livelihood opportunities for the artisans....

India Rapidly Expanding High Power Supercomputers

India is fast expanding its supercomputer facilities and developing the capacity to manufacture its own supercomputers in the country, the Ministry of Science and...

Cholesterol Medications May Lower Cancer-Related Deaths in Women

Among women with breast cancer, colorectal cancer, or melanoma, those who are taking cholesterol-lowering medications are less likely to die from cancer, researchers said. The...

Immediate Biomedical Waste Management Halts COVID Spread: UNIDO

The United Nations Industrial Development Organisation (UNIDO) on Tuesday stressed the need to halt the spread of COVID-19 through all possible infection channels, including...

1.16L Infant Deaths in 2019 Due to Air Pollution in India

The first-ever comprehensive analysis of air pollution's global impact on newborns finds that outdoor and household particulate matter pollution contributed to the deaths of...

Literature and Movies: Filmmaker Suman Mukhopadhyay

While reading 'Chuti Nakoch', a story by writer Ashapurna Devi, he suddenly felt grabbed by the jugular. It was tough to ignore the visual...

Recent Comments